Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
31 March 2016
Header
Header image
From our blog

From our blog

Collaboration through IMI Could Render Ebola a Disease of the Past
31 March 2016 by Magda Chlebus

Ebola may not strike the same note of fear that it did a matter of months ago, when it was ravaging the countries of West Africa and threatening to breach Europe’s health defences. Nevertheless its sporadic reappearance is a stark reminder that the fight against this deadly disease is by no means over and must be addressed continuously.

Read more

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
 
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
 
Please see the programmme for further details. Below, you can access the speakers' presentations:
 
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
 
 
Read more

Events Calendar

DIA 28th Annual EuroMeeting 2016
From 06/04/2016 to 08/04/2016 (Hamburg, Germany)

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer?

The DIA EuroMeeting is the premier platform on which to exchange ideas with thought leaders on key challenges and opportunities facing health care product development professionals. 

By attending EuroMeeting 2016, you will discuss issues while building relationships with your regulatory, industry and academia counterparts who are guiding the trends.

DOWNLOAD PROGRAMME

Read more

Events Calendar

ICH Info Day (this event is part of the pre-conference programme of the DIA EuroMeeting)
On 06/04/2016 (Hamburg, Germany)

This year’s Information Day will focus on the recent reforms within ICH and what this means for the global development of medicines. Participants will hear how ICH is moving towards becoming a truly global platform for regulators and industry, in order to achieve the objective of ‘Harmonisation for Better Health’.

Learn directly from the experts: 
Sessions include Q&A with: Dawn Ronan, Director of the ICH Secretariat; Tomas Salmonson EMA; and Richard Bergström, EFPIA, Belgium 

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

Events Calendar

EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Where do we currently stand with the implementation in different Member States
On 13/04/2016 (Brussels)

Organised by EFGCP with the partnership of EORTC

A revision of the Clinical Trials Regulation was adopted by European legislation makers in 2014. This revised legal framework will bring significant advances compared with today’s situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017).

For more information about the programme, please click here.

Read more

What we are reading

What we are reading

Despite potential benefits, big data faces resistance in healthcare
31 March 2016 (Science|Business)

Fears big data could affect insurance coverage and be used to track the performance of clinicians are holding back adoption. But big data means better data, according to speakers at a Science|Business conference

Read more

What we are reading

WHO downgrades Ebola health risk
31 March 2016 (BBC Health)

Ebola is no longer an "extraordinary health event" and the risk of the virus spreading is low, the World Health Organization says.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail